Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvain Ladoire

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2022
Associating Immunotherapy and Targeted Therapies: Facts and HopesSylvain Ladoire, Cédric Rébé, François Ghiringhelli
World Journal of Gastroenterology|February 23, 2013
Degarelix as a new antiangiogenic agent for metastatic colon cancer?Francois Ghiringhelli, Nicolas Isambert, Sylvain Ladoire
Cancer Immunology, Immunotherapy : CII|June 7, 2011
Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancerSylvain Ladoire, François Martin, François Ghiringhelli
Bulletin Du Cancer|July 5, 2020
[Non-clear cell renal cell carcinoma: clinico-biological characteristics and therapeutic management except surgery]Jonathan Thouvenin, Philippe Barthélémy, Sylvain Ladoire
World Journal of Gastroenterology|September 15, 2009
Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: a pilot studyFrancois Ghiringhelli, Boris Guiu, Bruno Chauffert, et al.
Bulletin Du Cancer|June 27, 2022
Advanced nccRCC: what therapeutic options in 2022?Cécile Bigot, Philippe Boudier, Sylvain Ladoire, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancerCaroline Truntzer, Nicolas Isambert, Laurent Arnould, et al.
Investigational New Drugs|October 23, 2015
Fluorouracil, leucovorin and irinotecan associated with aflibercept can induce microscopic colitis in metastatic colorectal cancer patientsFrançois Ghiringhelli, Julie Vincent, Françoise Beltjens, et al.
Investigational New Drugs|November 9, 2010
Bevacizumab plus FOLFIRI-3 in chemotherapy-refractory patients with metastatic colorectal cancer in the era of biotherapiesFrançois Ghiringhelli, Julie Vincent, Boris Guiu, et al.
Oncoimmunology|April 9, 2016
Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapySylvain Ladoire, David Enot, Fabrice Andre, et al.
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 29, 2022
Associating Immunotherapy and Targeted Therapies: Facts and HopesSylvain Ladoire, Cédric Rébé, François Ghiringhelli
World Journal of Gastroenterology|February 23, 2013
Degarelix as a new antiangiogenic agent for metastatic colon cancer?Francois Ghiringhelli, Nicolas Isambert, Sylvain Ladoire
Cancer Immunology, Immunotherapy : CII|June 7, 2011
Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancerSylvain Ladoire, François Martin, François Ghiringhelli
Bulletin Du Cancer|July 5, 2020
[Non-clear cell renal cell carcinoma: clinico-biological characteristics and therapeutic management except surgery]Jonathan Thouvenin, Philippe Barthélémy, Sylvain Ladoire
World Journal of Gastroenterology|September 15, 2009
Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: a pilot studyFrancois Ghiringhelli, Boris Guiu, Bruno Chauffert, et al.
Bulletin Du Cancer|June 27, 2022
Advanced nccRCC: what therapeutic options in 2022?Cécile Bigot, Philippe Boudier, Sylvain Ladoire, et al.
European Journal of Cancer (Oxford, England : 1990)|September 10, 2019
Prognostic value of transcriptomic determination of tumour-infiltrating lymphocytes in localised breast cancerCaroline Truntzer, Nicolas Isambert, Laurent Arnould, et al.
Investigational New Drugs|October 23, 2015
Fluorouracil, leucovorin and irinotecan associated with aflibercept can induce microscopic colitis in metastatic colorectal cancer patientsFrançois Ghiringhelli, Julie Vincent, Françoise Beltjens, et al.
Investigational New Drugs|November 9, 2010
Bevacizumab plus FOLFIRI-3 in chemotherapy-refractory patients with metastatic colorectal cancer in the era of biotherapiesFrançois Ghiringhelli, Julie Vincent, Boris Guiu, et al.
Oncoimmunology|April 9, 2016
Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapySylvain Ladoire, David Enot, Fabrice Andre, et al.
Pageof 17